Literature DB >> 5495393

The nephrotic syndrome as a complication of gold therapy.

C A Vaamonde, F R Hunt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5495393     DOI: 10.1002/art.1780130612

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  8 in total

Review 1.  Adverse reactions with oral and parenteral gold preparations.

Authors:  E C Tozman; N L Gottlieb
Journal:  Med Toxicol       Date:  1987 May-Jun

Review 2.  Drug-induced nephrotoxicity. Aetiology, clinical features and management.

Authors:  A J Hoitsma; J F Wetzels; R A Koene
Journal:  Drug Saf       Date:  1991 Mar-Apr       Impact factor: 5.606

3.  Gold nephropathy in rabbits using an indigenous preparation. A morphological study.

Authors:  A H Nagi; A H Khan
Journal:  Int Urol Nephrol       Date:  1984       Impact factor: 2.370

4.  beta 2-Microglobulin levels in serum and urine of rheumatoid arthritis patients on gold therapy.

Authors:  D Latt; J B Weiss; M I Jayson
Journal:  Ann Rheum Dis       Date:  1981-04       Impact factor: 19.103

5.  Mortality from amyloidosis and renal diseases in patients with rheumatoid arthritis.

Authors:  M Laakso; O Mutru; H Isomäki; K Koota
Journal:  Ann Rheum Dis       Date:  1986-08       Impact factor: 19.103

6.  Ten year mortality and causes of death in patients with rheumatoid arthritis.

Authors:  O Mutru; M Laakso; H Isomäki; K Koota
Journal:  Br Med J (Clin Res Ed)       Date:  1985-06-15

7.  Acute renal failure due to gold.

Authors:  G Robbins; M B McIllmurray
Journal:  Postgrad Med J       Date:  1980-05       Impact factor: 2.401

8.  The role of hypersensitivity and the immune response in influencing susceptibility to metal toxicity.

Authors:  G Kazantzis
Journal:  Environ Health Perspect       Date:  1978-08       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.